CHRONIC PHASE - prijevod na Hrvatskom

• kroničnoj fazi
• kronična faza
• kroničnu fazu
• kronične faze

Primjeri korištenja Chronic phase na Engleski i njihovi prijevodi na Hrvatskom

Except in newly diagnosed chronic phase CML, there are no controlled trials demonstrating a clinical benefit
Osim za novodijagnosticirani KML u kroničnoj fazi, ne postoje kontrolirana ispitivanja koja bi demonstrirala kliničku korist

A further study involving 519 patients compared Sprycel with imatinib in treating newly diagnosed Ph+ patients with chronic phase CML who had not received any previous treatment.
Daljnje ispitivanje obuhvatilo je 519 bolesnika i usporedilo je Sprycel s imatinibom u liječenju novodijagnosticiranih Ph+ bolesnika sa KML-om u kroničnoj fazi koji nisu prethodno primili terapiju.

Figure 2: MMR rates over time- all randomised patients in a phase 3 study of newly diagnosed patients with chronic phase CML.
Slika 2: Stope MMR tijekom vremena- svi randomizirani bolesnici u ispitivanju faze 3 provedenom u bolesnika s novodijagnosticiranom KML u kroničnoj fazi.

Table 3a: Selected adverse reactions reported in a phase 3 dose optimisation study(imatinib intolerant or resistant chronic phase CML)a.
Tablica 3a: Odabrane nuspojave prijavljene u ispitivanju optimizacije doze faze 3(bolesnici s KML u kroničnoj fazi koji ne podnose imatinib ili su otporni na njega)a.

more frequent in patients with advanced phase CML or Ph+ ALL than in chronic phase CML see section 4.4.
u uznapredovaloj fazi i bolesnika s Ph+ ALL nego u bolesnika s KML u kroničnoj fazi vidjeti dio 4.4.

subacute and chronic phase of the disease, taking age,
subakutnoj i kroničnoj fazi bolesti, uvažavajući pritom dob,

subacute and chronic phase of the disease was noticed in 12% of stroke patients with ischemia in the left brain hemisphere,
subakutnoj i kroničnoj fazi zabilježen je u 12% bolesnika s ishemijskim MU u lijevoj moždanoj hemisferi,

while the symptomatology itself passes into the chronic phase of the course, the patient's venous insufficiency,
sama simptomatologija prelazi u kroničnu fazu tečaja, pacijentova venska insuficijencija,

The effect of Glivec treatment on survival in chronic phase, newly diagnosed CML has been further examined in a retrospective analysis of the above reported Glivec data with the primary data from another Phase III study using IFN+Ara-C(n=325)
Učinak liječenja Glivecom na preživljenje u kroničnoj fazi novodijagnosticiranog KML-a je dodatno ispitivan u retrospektivnoj analizi gore navedenih Glivec podataka uz primarne podatke iz drugog ispitivanja faze III u kojem je primjenjivan INF+Ara-C(n=325)

reported as either complete haematological response, no evidence of leukaemia or return to chronic phase CML using the same criteria as for the study in accelerated phase..
stanje bez znakova leukemije ili kao vraćanje u kroničnu fazuKML- a, uz primjenu istih kriterija kao i kod ispitivanja u ubrzanoj fazi.

Patients had received a median of 14 months of prior IFN therapy at doses≥ 25 x 106 IU/week and were all in late chronic phase, with a median time from diagnosis of 32 months.
Bolesnici su prethodno primali IFN terapiju u medijanu trajanja od 14 mjeseci u dozama ≥25x 106 IU/tjedan i svi su bili u završnoj kroničnoj fazi, sa medijanom vremena od postavljanja dijagnoze od 32 mjeseca.

no evidence of leukaemia or return to chronic phase.
nemogućnost dokazivanja leukemije ili kao povratak u kroničnu fazu.

inflammation of the urethra can develop into a chronic phase, and this often leads to the development of complications,
upala mokraćne cijevi može razviti u kroničnoj fazi, a to često dovodi do razvoja komplikacija,

The data described below reflect exposure to Tasigna in 279 patients from a randomised Phase III study in patients with newly diagnosed Ph+ CML in chronic phase treated with 300 mg of nilotinib twice daily.
Podaci navedeni u nastavku prikazuju izloženost Tasigni u 279 bolesnika iz randomiziranog ispitivanja faze III u novodijagnosticiranih bolesnika s KML-om u kroničnoj fazi liječenih dozom od 300 mg nilotiniba dva puta na dan.

Out of 9 patients with chronic phase CML and cytogenetic data available,
Od 9 bolesnika s kroničnom fazom KML-a i raspoloživim citogenetskim podacima, 4(44%)

The dose of 340 mg/m2 daily is recommended for children and adolescents with chronic phase CML and advanced phase CML not to exceed the total dose of 800 mg.
Doza od 340 mg/m2 na dan preporučuju se za djecu i adolescente s kroničnom fazom KML-a i s uznapredovalom fazom KML-a ne smije se prekoračiti ukupna doza od 800 mg.

most experts suggest there is no benefit to adults with chronic phase Chagas disease.
većina stručnjaka predlažemo nema koristi za odrasle s kroničnim faze Chagas bolesti.

In 258 dasatinib-treated patients and 258 imatinib-treated patients with a minimum of 60 months follow-up in the Phase III study in newly diagnosed chronic phase CML, 1 patient(<
Od 258 bolesnika liječenih dasatinibom i 258 bolesnika liječenih imatinibom u ispitivanju faze III terapije novodijagnosticirane KML u kroničnoj fazi, nakon najmanje 60 mjeseci praćenja,

In the larger main study of patients with chronic phase CML, 90% of the patients responded to treatment, with blood levels of platelets
U većem glavnom ispitivanju provedenom na bolesnicima sa KML-om u kroničnoj fazi, 90% bolesnika odgovorilo je na terapiju,

In the newly diagnosed chronic phase CML study,
U ispitivanju novodijagnosticirane KML u kroničnoj fazi, nakon najmanje 12 mjeseci praćenja,